TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy‐associated tumours
Open Access
- 19 September 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (4) , 987-990
Abstract
The proposal has been put forward that the primary cause of Balkan endemic nephropathy (BEN) is exposure to food crops contaminated with seeds of Aristolochia spp, which contain high levels of aristolochic acids (AA). Recently, tumour DNA samples from patients with BEN were found to harbour principally A to T mutations in the TP53 tumour suppressor gene (Grollman et al., Proc Natl Acad Sci USA 2007;104:12129–34). Using a novel mutation assay in which we can induce and select mutations in human TP53 sequences in vitro by exposure of cultured cells to a mutagen, we found that A to T mutations were elicited by aristolochic acid at sites in TP53 rarely mutated in human cancers in general, but which were observed in the BEN patients. This concordance of specific mutations in patient tumours and aristolochic acid I‐exposed cultures supports the argument that AA has a direct role in the aetiology of BEN‐associated cancer.Keywords
This publication has 16 references indexed in Scilit:
- Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathyMutation Research - Reviews in Mutation Research, 2008
- Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72Oncogene, 2007
- Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancerCarcinogenesis, 2007
- Aristolochic acid and the etiology of endemic (Balkan) nephropathyProceedings of the National Academy of Sciences, 2007
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007
- Polymorphisms in the p53 pathwayOncogene, 2006
- p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung TumorsCancer Research, 2005
- Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 geneProceedings of the National Academy of Sciences, 2004
- Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research toolOncogene, 2001
- Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)New England Journal of Medicine, 2000